MIMichał Iwanicki

Michał Iwanicki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michał Iwanicki has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Limitations of Fried frailty criteria in kidney transplant recipients with arteriovenous fistulas

    by Anna Królicka, Magdalena Kuriata-Kordek, Michał Iwanicki, Mirosław Banasik, Krzysztof Letachowicz

    Background: Kidney transplant recipients (KTRs) are prone to development of muscle dysfunction and frailty. This study aimed to assess muscle strength and body composition alterations in KTRs, and whether an arteriovenous fistula (AVF) can influence handgrip strength (HGS) results in KTRs. Methods: One hundred fifty-six KTRs were recruited for the prospective, observational study. Both HGS tests and Timed Up and Go test were carried out. HGS results were analyzed taking into consideration the localization of AVF and hand domination. Results: Impaired mobility was identified in 34% of KTRs, while frailty was suspected in almost 13%. HGS differed in patients with an AVF on dominant arm, and equaled 29.5 (20–42), as compared to patients with no AVF on dominant arm with HGS 38 (28–48), p = 0.044. Conclusions: Impaired mobility is a common problem in the KTR population. The presence of an AVF influences HGS results. The diagnosis of frailty based on Fried criteria may not be valid in KTRs with an AVF, irrespective of its patency. Clinical Trial Registration number: NCT04478968, https://clinicaltrials.gov/search?term=NCT04478968

  • Open Access

    The Impact of Erectile Dysfunction on Quality of Life and Mental Health in Men

    by Jakub Hobot, Michał Iwanicki, Maciej Hobot

    Erectile dysfunction (ED) is a prevalent and multifactorial condition that affects men worldwide, with vascular, hormonal, neurological, and psychological factors contributing to its development. Beyond impairing sexual performance, ED has significant consequences for mental health, quality of life, and interpersonal relationships, and may serve as an early indicator of systemic diseases such as cardiovascular disease and metabolic syndrome. Men with ED frequently experience depression, anxiety, reduced self-esteem, and relational difficulties, highlighting the importance of evaluating both psychological and physical health in this population. Effective management includes pharmacological interventions such as sildenafil or tadalafil, psychosexual therapy, and lifestyle modifications, all of which can improve erectile function as well as psychological well-being. A holistic, multidisciplinary approach involving primary care physicians, urologists, and mental health professionals is essential to optimize outcomes and address both the physiological and psychosocial aspects of ED. Recognizing ED as a multidimensional condition underscores the need for comprehensive assessment and integrated care strategies to enhance quality of life and overall health in affected men.